KACTUS Blog

PTK7: Exploring a Promising Target for Cancer Therapeutics
PTK7: Exploring a Promising Target for Cancer Therapeutics
The Rise of the CDH6 Target: Next-Generation ADC Drugs Lead New Breakthroughs in Ovarian Cancer Treatment
The Rise of the CDH6 Target: Next-Generation ADC Drugs Lead New Breakthroughs in Ovarian Cancer Treatment
IL-23: A Key Target for the Treatment of Immune-Mediated Inflammatory Diseases
IL-23: A Key Target for the Treatment of Immune-Mediated Inflammatory Diseases
The Pan-RAS Breakthrough: Doubling Survival Rates in Pancreatic Cancer
The Pan-RAS Breakthrough: Doubling Survival Rates in Pancreatic Cancer
AACR 2026 Spotlight: ALPP/ALPPL2 Emerges as The New Frontier of Precision Oncology
AACR 2026 Spotlight: ALPP/ALPPL2 Emerges as The New Frontier of Precision Oncology
TCE Antibody Screening Applying Native-like KACTUS TCR-CD3 Complexes to Drug Discovery
TCE Antibody Screening Applying Native-like KACTUS TCR-CD3 Complexes to Drug Discovery
Unlock True Biological Signals by Eliminating Endotoxin Noise - Animal Immunization
Unlock True Biological Signals by Eliminating Endotoxin Noise - Animal Immunization
Targeting IL-25: A New Exploration in the Treatment of Type 2 Inflammation
Targeting IL-25: A New Exploration in the Treatment of Type 2 Inflammation
Panoramic View of the Kallikrein Family: From Structure and Function to Disease and Drug Development
Panoramic View of the Kallikrein Family: From Structure and Function to Disease and Drug Development
1 2 3 … 7

Explore more

  • Antibody Drug Discovery
  • Assay Kits
  • Cell Therapy
  • Company News
  • Gene Editing
  • GPCRs
  • Membrane Proteins
  • MHC/TCR
  • Product Highlights
  • Recombinant Proteins
  • RNA/DNA
  • VLP & Nanodisc Proteins
  • VLP and Nanodisc Proteins
  • VLP Proteins

    • Popular posts

    Beyond Refolding: The Case for Mammalian-Expressed Single-Chain Trimer MHCs
    Beyond Refolding: The Case for Mammalian-Expressed Single-Chain Trimer MHCs
    Sep 18, 2024
    IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme
    IND Approval for Solid Tumor Therapy Using KACTUS Cas9 Enzyme
    Jul 24, 2024